Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-26

Clinical Trial Update: Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg [Phase 3]

View source ↗

Summary

A Phase 3 trial completed evaluating the safety and efficacy of rosuvastatin 40 mg in combination with ezetimibe 10 mg in patients with high cholesterol and car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED